2) I have seen in the last 10 years of looking at biotech BO's after BLA and before PDUFA
3) That PR you provided states "The BioLexis reorganization, which does not entail any changes in the indirect ownership of Outlook Therapeutics, provides GMS Holdings with increased flexibility to support the future growth of Outlook Therapeutics as its largest shareholder. "
A BO is at least conceivable. I wonder if the current PPS is ripe for it and what the Buyer would be willing to go on top of the current pps.